Company Matinas BioPharma Holdings Inc Other OTC
Equities
US5768101058
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Pharmaceutical Products
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -65.62% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -65.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
James Ferguson
CTO | Chief Tech/Sci/R&D Officer | 70 | 19-02-24 |
Corporate Officer/Principal | 56 | 18-10-14 | |
Thomas Hoover
PRN | Corporate Officer/Principal | 55 | 21-12-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
James Scibetta
BRD | Director/Board Member | 59 | 13-10-31 |
Matthew Wikler
BRD | Director/Board Member | 74 | 17-12-31 |
Kathryn Corzo
BRD | Director/Board Member | 63 | 21-08-31 |
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 250,816,164 | 244,482,252 ( 97.47 %) | 0 | 97.47 % |
Company contact information
Matinas BioPharma Holdings, Inc.
1545 Route 206 South Suite 302
07921-9999, Bedminster
+908 484 8805
http://www.matinasbiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- MTNB Stock
- Stock
- Company Matinas BioPharma Holdings Inc